Arrhythmia Market Is Booming Worldwide 2025-2032 | Pfizer Inc, Sanofi SA, GlaxoSmithKline plc, Novartis AG
The global arrhythmia market is estimated to be valued at USD 17.21 Bn in 2025 and is expected to reach USD 24.38 Bn by 2032. BURLINGAME, CALIFORNIA , UNITED STATES, October 1, 2025 /EINPresswire.com/ -- The latest report from Coherent Market …